+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Transdermal Patch Market Research Report 2022 (Status and Outlook)

  • ID: 5574516
  • Report
  • February 2022
  • Region: Global
  • 126 Pages
  • Bosson Research

FEATURED COMPANIES

  • Bayer
  • Dr Reddy’s Laboratories
  • Grünenthal
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Mundipharma
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

The Global Transdermal Patch Market Size was estimated at USD 6793.00 million in 2021 and is projected to reach USD 8701.22 million by 2028, exhibiting a CAGR of 3.60% during the forecast period.

This latest report provides a deep insight into the global Transdermal Patch market covering all its essential aspects. This ranges from macro-overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies to the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of Global Transdermal Patch Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transdermal Patch market in any manner.

Global Transdermal Patch Market: Market Segmentation Analysis


The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Market segmentation creates subsets of a market based on product type, end user or application, Geographic, and other factor. By understanding the market segments, decision maker can leverage this targeting in product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Companies

  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grünenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

Market Segmentation (by Type)

  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others

Market Segmentation (by Application)

  • Rx Channel
  • OTC Channel

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Market
  • Overview of the regional outlook of the Market

Key Reasons to Buy this Report:

  • Access to up to date statistics compiled by our own researchers. These provide you with historical and forecast data, which is analysed to tell you why your market is set to change
  • This enables you to anticipate market changes in order to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentation or other strategic documents
  • The concise analysis, clear graph and table format will enable you to pin point the information your require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer
  • Dr Reddy’s Laboratories
  • Grünenthal
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Mundipharma

1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Transdermal Patch
1.2 Key Market Segments
1.2.1 Transdermal Patch Segment by Type
1.2.2 Transdermal Patch Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Transdermal Patch Market Overview
2.1 Global Market Overview
2.1.1 Global Transdermal Patch Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Transdermal Patch Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Transdermal Patch Market Competitive Landscape
3.1 Global Transdermal Patch Sales by Manufacturers (2017-2022)
3.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2017-2022)
3.3 Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Transdermal Patch Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Transdermal Patch Sales Sites, Area Served, Product Type
3.6 Transdermal Patch Market Competitive Situation and Trends
3.6.1 Transdermal Patch Market Concentration Rate
3.6.2 Global 5 and 10 Largest Transdermal Patch Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Transdermal Patch Industry Chain Analysis
4.1 Transdermal Patch Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Transdermal Patch Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Transdermal Patch Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transdermal Patch Sales Market Share by Type (2017-2022)
6.3 Global Transdermal Patch Market Size Market Share by Type (2017-2022)
6.4 Global Transdermal Patch Price by Type (2017-2022)
7 Transdermal Patch Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transdermal Patch Market Sales by Application (2017-2022)
7.3 Global Transdermal Patch Market Size (M USD) by Application (2017-2022)
7.4 Global Transdermal Patch Sales Growth Rate by Application (2017-2022)
8 Transdermal Patch Market Segmentation by Region
8.1 Global Transdermal Patch Sales by Region
8.1.1 Global Transdermal Patch Sales by Region
8.1.2 Global Transdermal Patch Sales Market Share by Region
8.2 North America
8.2.1 North America Transdermal Patch Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Transdermal Patch Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Transdermal Patch Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Transdermal Patch Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Transdermal Patch Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Hisamitsu Pharmaceutical
9.1.1 Hisamitsu Pharmaceutical Transdermal Patch Basic Information
9.1.2 Hisamitsu Pharmaceutical Transdermal Patch Product Overview
9.1.3 Hisamitsu Pharmaceutical Transdermal Patch Product Market Performance
9.1.4 Hisamitsu Pharmaceutical Business Overview
9.1.5 Hisamitsu Pharmaceutical Transdermal Patch SWOT Analysis
9.1.6 Hisamitsu Pharmaceutical Recent Developments
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Transdermal Patch Basic Information
9.2.2 Johnson & Johnson Transdermal Patch Product Overview
9.2.3 Johnson & Johnson Transdermal Patch Product Market Performance
9.2.4 Johnson & Johnson Business Overview
9.2.5 Johnson & Johnson Transdermal Patch SWOT Analysis
9.2.6 Johnson & Johnson Recent Developments
9.3 Novartis
9.3.1 Novartis Transdermal Patch Basic Information
9.3.2 Novartis Transdermal Patch Product Overview
9.3.3 Novartis Transdermal Patch Product Market Performance
9.3.4 Novartis Business Overview
9.3.5 Novartis Transdermal Patch SWOT Analysis
9.3.6 Novartis Recent Developments
9.4 UCB Pharma
9.4.1 UCB Pharma Transdermal Patch Basic Information
9.4.2 UCB Pharma Transdermal Patch Product Overview
9.4.3 UCB Pharma Transdermal Patch Product Market Performance
9.4.4 UCB Pharma Business Overview
9.4.5 UCB Pharma Transdermal Patch SWOT Analysis
9.4.6 UCB Pharma Recent Developments
9.5 Mylan
9.5.1 Mylan Transdermal Patch Basic Information
9.5.2 Mylan Transdermal Patch Product Overview
9.5.3 Mylan Transdermal Patch Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Transdermal Patch SWOT Analysis
9.5.6 Mylan Recent Developments
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Transdermal Patch Basic Information
9.6.2 Teva Pharmaceutical Transdermal Patch Product Overview
9.6.3 Teva Pharmaceutical Transdermal Patch Product Market Performance
9.6.4 Teva Pharmaceutical Business Overview
9.6.5 Teva Pharmaceutical Recent Developments
9.7 Nitto Denko
9.7.1 Nitto Denko Transdermal Patch Basic Information
9.7.2 Nitto Denko Transdermal Patch Product Overview
9.7.3 Nitto Denko Transdermal Patch Product Market Performance
9.7.4 Nitto Denko Business Overview
9.7.5 Nitto Denko Recent Developments
9.8 Grünenthal
9.8.1 Grünenthal Transdermal Patch Basic Information
9.8.2 Grünenthal Transdermal Patch Product Overview
9.8.3 Grünenthal Transdermal Patch Product Market Performance
9.8.4 Grünenthal Business Overview
9.8.5 Grünenthal Recent Developments
9.9 IBSA Group
9.9.1 IBSA Group Transdermal Patch Basic Information
9.9.2 IBSA Group Transdermal Patch Product Overview
9.9.3 IBSA Group Transdermal Patch Product Market Performance
9.9.4 IBSA Group Business Overview
9.9.5 IBSA Group Recent Developments
9.10 GSK
9.10.1 GSK Transdermal Patch Basic Information
9.10.2 GSK Transdermal Patch Product Overview
9.10.3 GSK Transdermal Patch Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Luye Pharma Group
9.11.1 Luye Pharma Group Transdermal Patch Basic Information
9.11.2 Luye Pharma Group Transdermal Patch Product Overview
9.11.3 Luye Pharma Group Transdermal Patch Product Market Performance
9.11.4 Luye Pharma Group Business Overview
9.11.5 Luye Pharma Group Recent Developments
9.12 Pfizer
9.12.1 Pfizer Transdermal Patch Basic Information
9.12.2 Pfizer Transdermal Patch Product Overview
9.12.3 Pfizer Transdermal Patch Product Market Performance
9.12.4 Pfizer Business Overview
9.12.5 Pfizer Recent Developments
9.13 Chattem
9.13.1 Chattem Transdermal Patch Basic Information
9.13.2 Chattem Transdermal Patch Product Overview
9.13.3 Chattem Transdermal Patch Product Market Performance
9.13.4 Chattem Business Overview
9.13.5 Chattem Recent Developments
9.14 Dr Reddy’s Laboratories
9.14.1 Dr Reddy’s Laboratories Transdermal Patch Basic Information
9.14.2 Dr Reddy’s Laboratories Transdermal Patch Product Overview
9.14.3 Dr Reddy’s Laboratories Transdermal Patch Product Market Performance
9.14.4 Dr Reddy’s Laboratories Business Overview
9.14.5 Dr Reddy’s Laboratories Recent Developments
9.15 Bayer
9.15.1 Bayer Transdermal Patch Basic Information
9.15.2 Bayer Transdermal Patch Product Overview
9.15.3 Bayer Transdermal Patch Product Market Performance
9.15.4 Bayer Business Overview
9.15.5 Bayer Recent Developments
9.16 Mundipharma
9.16.1 Mundipharma Transdermal Patch Basic Information
9.16.2 Mundipharma Transdermal Patch Product Overview
9.16.3 Mundipharma Transdermal Patch Product Market Performance
9.16.4 Mundipharma Business Overview
9.16.5 Mundipharma Recent Developments
9.17 Endo International
9.17.1 Endo International Transdermal Patch Basic Information
9.17.2 Endo International Transdermal Patch Product Overview
9.17.3 Endo International Transdermal Patch Product Market Performance
9.17.4 Endo International Business Overview
9.17.5 Endo International Recent Developments
9.18 Beijing Tide Pharmaceutical
9.18.1 Beijing Tide Pharmaceutical Transdermal Patch Basic Information
9.18.2 Beijing Tide Pharmaceutical Transdermal Patch Product Overview
9.18.3 Beijing Tide Pharmaceutical Transdermal Patch Product Market Performance
9.18.4 Beijing Tide Pharmaceutical Business Overview
9.18.5 Beijing Tide Pharmaceutical Recent Developments
10 Transdermal Patch Market Forecast by Region
10.1 Global Transdermal Patch Market Size Forecast
10.2 Global Transdermal Patch Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Transdermal Patch Market Size Forecast by Country
10.2.3 Asia Pacific Transdermal Patch Market Size Forecast by Region
10.2.4 South America Transdermal Patch Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Transdermal Patch by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Transdermal Patch Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Transdermal Patch by Type (2022-2028)
11.1.2 Global Transdermal Patch Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Transdermal Patch by Type (2022-2028)
11.2 Global Transdermal Patch Market Forecast by Application (2022-2028)
11.2.1 Global Transdermal Patch Sales (K Units) Forecast by Application
11.2.2 Global Transdermal Patch Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
Note: Product cover images may vary from those shown
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grünenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • End
Note: Product cover images may vary from those shown

Loading
LOADING...